Suchergebnisse - "Bosch-Barrera, Joaquim"

PubPharm (143)

1

Describing differences among populations of thoracic tumors patients under and over 80 years : Data analysis from the SLCG thoracic tumor registry

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Provencio, M. | Cobo, M. | Rodriguez-Abreu, D. | +20

2

Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC) : 2023 expert consensus of the Spanish Lung Cancer Group GECP

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Ospina, A. | Bolufer Nadal, S. | Campo-Cañaveral de la Cruz, J. | +26

3

Silibinin is a suppressor of the metastasis-promoting transcription factor ID3

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Verdura, S. | Encinar, J. | Gratchev, A. | +10

4

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients

enthalten in: Archivos de bronconeumologia | 2024

von Candal-Pedreira, C. | Ruano-Ravina, A. | Calvo de Juan, V. | +21

5

STAR-121 : A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations

enthalten in: Clinical lung cancer | 2024

von Rodriguez-Abreu, D. | Bosch-Barrera, J. | Gray, J. | +8

6

Brief report : High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer

enthalten in: Thrombosis research | 2023

von Aparicio, I. | Iranzo, P. | Reyes, R. | +27

7

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2023

von Riudavets, M. | Auclin, E. | Mosteiro, M. | +36

8

Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria : cross-sectional study

enthalten in: ERJ open research | 2023

von Candal-Pedreira, C. | Ruano-Ravina, A. | Calvo de Juan, V. | +22

9

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain : a nationwide cohort study

enthalten in: Translational lung cancer research | 2023

von Provencio, M. | Carcereny, E. | López Castro, R. | +17

10

Immunogenicity of COVID-19 vaccines in lung cancer patients

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Provencio, M. | Estival, A. | Franco, F. | +28

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]